Small intestine neuromuscular dysfunction in a mouse model of dextran sulfate sodium-induced ileitis: Involvement of dopaminergic neurotransmission.

[1]  K. Gil,et al.  Gastrointestinal Dopamine in Inflammatory Bowel Diseases: A Systematic Review , 2021, International journal of molecular sciences.

[2]  E. Savarino,et al.  Influence of Tilia tomentosa Moench Extract on Mouse Small Intestine Neuromuscular Contractility , 2021, Nutrients.

[3]  M. Arends,et al.  Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines , 2021, Journal of Crohn's & colitis.

[4]  Yuying Jiang,et al.  DA-DRD5 signaling controls colitis by regulating colonic M1/M2 macrophage polarization , 2021, Cell Death & Disease.

[5]  D. Mantini,et al.  Dopamine Transporter Genetic Reduction Induces Morpho-Functional Changes in the Enteric Nervous System , 2021, Biomedicines.

[6]  D. Guidolin,et al.  Experimental Evidence of A2A–D2 Receptor–Receptor Interactions in the Rat and Human Carotid Body , 2021, Frontiers in Physiology.

[7]  Yifei Feng,et al.  Immunomodulatory Effects of Dopamine in Inflammatory Diseases , 2021, Frontiers in Immunology.

[8]  M. Farrer,et al.  Dynamic control of the dopamine transporter in neurotransmission and homeostasis , 2021, NPJ Parkinson's disease.

[9]  A. Baj,et al.  Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease , 2021, International journal of molecular sciences.

[10]  R. Franco,et al.  Dopamine in Health and Disease: Much More Than a Neurotransmitter , 2021, Biomedicines.

[11]  N. Salinas-Jazmín,et al.  Dopamine Receptors in Cancer: Are They Valid Therapeutic Targets? , 2021, Technology in cancer research & treatment.

[12]  S. O'Mahony,et al.  Oxidized phospholipids affect small intestine neuromuscular transmission and serotonergic pathways in juvenile mice , 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[13]  S. Vermeire,et al.  Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links , 2020, Gut.

[14]  K. Keay,et al.  Dopamine: an immune transmitter , 2020, Neural regeneration research.

[15]  Z. Nemeth,et al.  Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity , 2020, Cells.

[16]  M. Giron,et al.  Involvement of Enteric Glia in Small Intestine Neuromuscular Dysfunction of Toll-Like Receptor 4-Deficient Mice , 2020, Cells.

[17]  K. Whitehead,et al.  Expanding the utility of the dextran sulfate sodium (DSS) mouse model to induce a clinically relevant loss of intestinal barrier function , 2020, PeerJ.

[18]  Z. Nemeth,et al.  Colonic dysmotility associated with high‐fat diet‐induced obesity: Role of enteric glia , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  A. Grimaldi,et al.  Homeoprotein OTX1 and OTX2 involvement in rat myenteric neuron adaptation after DNBS-induced colitis , 2020, PeerJ.

[20]  A. Amato,et al.  Opposite effects of dopamine on the mechanical activity of circular and longitudinal muscle of human colon , 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[21]  M. Conconi,et al.  S100B as a new fecal biomarker of inflammatory bowel diseases. , 2020, European review for medical and pharmacological sciences.

[22]  T. H. Nguyen,et al.  The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The lancet. Gastroenterology & hepatology.

[23]  Monya Baker,et al.  The ARRIVE guidelines 2019: updated guidelines for reporting animal research , 2019, bioRxiv.

[24]  R. Kellermayer,et al.  Weight loss is a sufficient and economical single outcome measure of murine dextran sulfate sodium colitis , 2019, FASEB bioAdvances.

[25]  K. Tripathi,et al.  New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance , 2019, Drugs in context.

[26]  Yun Li,et al.  Dopamine promotes colonic mucus secretion through dopamine D5 receptor in rats. , 2019, American journal of physiology. Cell physiology.

[27]  P. Vidal,et al.  Targeting the Dopaminergic System in Autoimmunity , 2019, Journal of Neuroimmune Pharmacology.

[28]  F. Michetti,et al.  The S100B story: from biomarker to active factor in neural injury , 2018, Journal of neurochemistry.

[29]  M. Montopoli,et al.  The ecto-enzymes CD73 and adenosine deaminase modulate 5′-AMP-derived adenosine in myofibroblasts of the rat small intestine , 2018, Purinergic Signalling.

[30]  C. Scarpignato,et al.  Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity , 2018, International Journal of Obesity.

[31]  M. Giron,et al.  Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease , 2018, International journal of molecular sciences.

[32]  Steve Alexander,et al.  Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers , 2018, British journal of pharmacology.

[33]  S. Liao,et al.  Acute small intestinal inflammation results in persistent lymphatic alterations. , 2018, American journal of physiology. Gastrointestinal and liver physiology.

[34]  H. Bohnenberger,et al.  Impaired resolution of DSS-induced colitis in mice lacking the glucocorticoid receptor in myeloid cells , 2018, PloS one.

[35]  C. Scarpignato,et al.  Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors , 2017, Purinergic Signalling.

[36]  M. Rugge,et al.  Antibiotic‐induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice , 2017, British journal of pharmacology.

[37]  Nicholas W Wood,et al.  Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases , 2017, JAMA neurology.

[38]  M. Rugge,et al.  Toll-Like Receptor 4 Modulates Small Intestine Neuromuscular Function through Nitrergic and Purinergic Pathways , 2017, Front. Pharmacol..

[39]  Stefan Wirtz,et al.  Chemically induced mouse models of acute and chronic intestinal inflammation , 2017, Nature Protocols.

[40]  F. Cominelli,et al.  Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn’s Disease–Like Ileitis: What is the Right Model? , 2017, Cellular and molecular gastroenterology and hepatology.

[41]  Kathryn E. Crosier,et al.  A whole animal chemical screen approach to identify modifiers of intestinal neutrophilic inflammation , 2017, The FEBS journal.

[42]  H. Veiga-Fernandes,et al.  Neuroimmune regulation during intestinal development and homeostasis , 2017, Nature Immunology.

[43]  A. Mai,et al.  A new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stability , 2017, Journal of enzyme inhibition and medicinal chemistry.

[44]  N. Saadé,et al.  Impairment of Small Intestinal Function in Ulcerative Colitis: Role of Enteric Innervation , 2016, Journal of Crohn's & colitis.

[45]  A. Amato,et al.  Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors , 2016, Journal of Physiology and Biochemistry.

[46]  C. Pellegrini,et al.  Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration , 2016, Journal of Neuroinflammation.

[47]  F. Mosca,et al.  Postnatal development of the dopaminergic signaling involved in the modulation of intestinal motility in mice , 2016, Pediatric Research.

[48]  S. Matsushita,et al.  Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses , 2015, Journal of Neuroimmunology.

[49]  S. Szabó,et al.  Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease , 2015, Digestive Diseases and Sciences.

[50]  Lei Liu,et al.  Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome , 2015, Cell.

[51]  F. Contreras,et al.  The Dopaminergic System in Autoimmune Diseases , 2014, Front. Immunol..

[52]  B. Chassaing,et al.  Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice , 2014, Current protocols in immunology.

[53]  A. Rosato,et al.  Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. , 2013, Gastroenterology.

[54]  P. Brun,et al.  Adenosine-Mediated Enteric Neuromuscular Function Is Affected during Herpes Simplex Virus Type 1 Infection of Rat Enteric Nervous System , 2013, PloS one.

[55]  J. Wallace,et al.  Dextran sulfate sodium induces pan-gastroenteritis in rodents: implications for studies of colitis. , 2012, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[56]  R. Gainetdinov,et al.  The Physiology, Signaling, and Pharmacology of Dopamine Receptors , 2011, Pharmacological Reviews.

[57]  Masashi Iwasaki,et al.  Orally administered soymorphins, soy-derived opioid peptides, suppress feeding and intestinal transit via gut mu(1)-receptor coupled to 5-HT(1A), D(2), and GABA(B) systems. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[58]  F. Mulè,et al.  D1 receptors play a major role in the dopamine modulation of mouse ileum contractility. , 2010, Pharmacological research.

[59]  R. Köhling,et al.  Dopamine induces contraction in the proximal, but relaxation in the distal rat isolated small intestine , 2009, Neuroscience Letters.

[60]  P. Alex,et al.  Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS‐Induced Colitis , 2009, Inflammatory bowel diseases.

[61]  Dean P. Jones,et al.  Targeted Deletion of Neuropeptide Y (NPY) Modulates Experimental Colitis , 2008, PloS one.

[62]  R. Mailman,et al.  Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: Potential interaction with A2A and D2-like receptors , 2006, Brain Research.

[63]  M. Gershon,et al.  Physiological Modulation of Intestinal Motility by Enteric Dopaminergic Neurons and the D2 Receptor: Analysis of Dopamine Receptor Expression, Location, Development, and Function in Wild-Type and Knock-Out Mice , 2006, The Journal of Neuroscience.

[64]  G. Sigurdsson,et al.  Effects of Dopamine, Dobutamine, and Dopexamine on Microcirculatory Blood Flow in the Gastrointestinal Tract during Sepsis and Anesthesia , 2004, Anesthesiology.

[65]  G. Corazza,et al.  Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics , 2004, Alimentary pharmacology & therapeutics.

[66]  Scott F. Hall,et al.  Enteric Dopaminergic Neurons: Definition, Developmental Lineage, and Effects of Extrinsic Denervation , 2003, The Journal of Neuroscience.

[67]  F. Magro,et al.  Impaired synthesis or cellular storage of norepinephrine, dopamine and 5-hydroxytryptamine in inflammatory bowel disease , 2000, American Journal of Gastroenterology.

[68]  R. Carey,et al.  Identification and regional distribution of the dopamine D(1A) receptor in the gastrointestinal tract. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[69]  R. Gainetdinov,et al.  Mice lacking the dopamine transporter display altered regulation of distal colonic motility. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[70]  J. Jamart,et al.  Effect of dopamine on gastrointestinal motility during critical illness , 2000, Intensive Care Medicine.

[71]  É. Mezey,et al.  Substantial production of dopamine in the human gastrointestinal tract. , 1997, The Journal of clinical endocrinology and metabolism.

[72]  M. Tonini,et al.  Recent advances in the pharmacology of gastrointestinal prokinetics. , 1996, Pharmacological research.

[73]  F. Clubb,et al.  The effect of euthanasia technique on vascular arachidonic acid metabolism and vascular and intestinal smooth muscle contractility. , 1990, Laboratory animal science.